Cargando…
Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine
A dysregulated response to systemic inflammation is a common pathophysiological feature of most conditions encountered in the intensive care unit (ICU). Recent evidence indicates that a dysregulated inflammatory response is involved in the pathogenesis of various ICU-related disorders associated wit...
Autores principales: | Cioccari, Luca, Luethi, Nora, Masoodi, Mojgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724037/ https://www.ncbi.nlm.nih.gov/pubmed/33324417 http://dx.doi.org/10.3389/fimmu.2020.599853 |
Ejemplares similares
-
Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study
por: Luethi, Nora, et al.
Publicado: (2016) -
The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
por: Crisman, Marco, et al.
Publicado: (2017) -
Editorial: “Toward Precision Medicine in Vasculitis”
por: Alberici, Federico, et al.
Publicado: (2020) -
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017) -
Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial
por: Cioccari, Luca, et al.
Publicado: (2023)